April 27, 1996 |
Cancer rates have increased slightly for black men, still the Americans most likely to get and die of cancer, according to a National Cancer Institute study. The study found that black men had a general cancer rate of 560 cases per 100,000 people and a cancer death rate of 319 per 100,000. Statistics released last year showed a cancer rate of 557 per 100,000 and a cancer death rate of 316 per 100,000 for black males.
October 1, 2005 |
Andrew von Eschenbach, named last week as interim Food and Drug Administration commissioner to replace Lester Crawford, will take a leave of absence from his job as director of the National Cancer Institute, Sen. Barbara Mikulski said. Von Eschenbach also will "refrain from selected FDA activities that may be seen as a conflict of interest," Mikulski, a Maryland Democrat, said in a statement.
December 5, 1985 |
News of a promising new cancer treatment at the National Cancer Institute prompted a flood of calls to the federal center today from people desperate for a cure from the disease. The callers want information about a new treatment, called adoptive immunotherapy, that turns ordinary white blood cells into "killer cells" that attack malignant tumors. The treatment was announced Wednesday in an article in the New England Journal of Medicine. (Story, Page 12)
March 18, 1989 |
Former U.S. Rep. Bill Chappell Jr. (D-Fla.), defeated last year after 20 years in Congress, said Friday that he is being treated for bone cancer. Chappell, 67, was admitted to the Warren Grant Magnuson Clinical Center in Bethesda, Md., on Feb. 23 by the National Cancer Institute and is in stable condition, a spokeswoman said.
November 5, 1994 |
Test-tube experiments at a National Institutes of Health laboratory show evidence that a drug called hydroxyurea may block or slow the replication of the AIDS virus, researchers report. In a study published in the journal Science, researchers at the National Cancer Institute report that HIV, which causes AIDS, is unable to reproduce in cells exposed to hydroxyurea, a cancer drug that has been used for 30 years.
February 27, 1993 |
Guidelines for breast cancer screening could be changed by some medical organizations once they fully analyze new studies showing mammograms may provide little benefit for women before age 50, officials said. Dr. Gerald P. Murphy, chief medical officer at the American Cancer Society, said his group is examining the new studies, but "not all of the information has been evaluated, and there are no conclusions that can be made on this as yet."